Shanghai-based 111 In., which runs an online retail drugstore and healthcare platform in China, has filed for U.S. initial public offering to raise US$200 million under the name YI, according to its prospectus.
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access Over 11,000 stories and data posts over the past 8 years!Register Now
Already have an account or paid subscription?